Google AI ModeSep 19, 2026
Bpifrance (France) : Functioning as a hybrid sovereign/public investment bank, Bpifrance has massive direct seed and early-stage venture funds
Data as of Oct 15, 2026Based on 3,806 AI responses
Reviewed by Dimitry Apollonsky
AI summary
Bpifrance is the French public investment bank that provides funding, bank loans, and investment support to help French companies develop internationally.
<1%
of 3,806 answers across Bpifrance’s markets · since Jul 5
The market map
Private Market Investor FinderMentioned in
Share of answers in Private Market Investor Finder each week · 508 answers since Jul 5
Each engine’s share of its own answers across Bpifrance’s markets · since Jul 5
This page was cited in 2 AI answers that named Bpifrance.
Review how this page presents the business before deciding whether to contact its publisher. The citation evidence does not establish that the page mentions the brand or needs a correction.
All-time evidence through 2026-10-15.
Review the page on bcg.com (opens in a new tab)Where Bpifrance ranks in AI
Question: I'm looking for sovereign wealth funds that do direct early-stage investing.
Google AI ModeAug 18, 2026
Bpifrance (France) : Operating as a public investment bank and sovereign-adjacent vehicle, Bpifrance runs dedicated direct seed and venture funds
Question: I need to find investors for my deep tech startup with a long R&D timeline. Which funds are known for their "patient capital"?
Google AI ModeJul 22, 2026
Bpifrance : Provides significant patient capital through subsidies, loans, and equity investments in European deep tech.
bpifrance.com 22%Other sites 78%
Excerpts where Bpifrance appeared in the AI's answer
Bpifrance (France) : Functioning as a hybrid sovereign/public investment bank, Bpifrance has massive direct seed and early-stage venture funds
Bpifrance (France) : Operating as a public investment bank and sovereign-adjacent vehicle, Bpifrance runs dedicated direct seed and venture funds
Excerpts where Bpifrance appeared in the AI's answer
Bpifrance : Provides significant patient capital through subsidies, loans, and equity investments in European deep tech.